Largest Biotechnology Companies by Market Cap
Explore the biggest and most valuable companies in the Biotechnology sector ranked by market capitalization
Biotechnology Industry Market Cap: $1.44 Trillion Total Companies: 1,738
Total Market Cap (USD)
$1.44 Trillion
Companies Listed
1,738
Largest Company
Keros Therapeutics Inc
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 451 |
Keros Therapeutics Inc
NASDAQ:KROS |
$270.55 Million | $270.55 Million | USA | $11.34 | +2.81% | -0.09% | 9.99 Million |
| 452 |
Yantai Zhenghai Bio-Tech Co Ltd
SHE:300653 |
$269.66 Million | CN¥1.98 Billion | China | CN¥20.12 | -1.08% | +0.30% | 42.68 Million |
| 453 |
Ever Supreme Bio Technology Co. Ltd
TWO:6712 |
$268.60 Million | NT$8.89 Billion | Taiwan | NT$140.50 | -1.06% | -3.44% | 8.34 Million |
| 454 |
Enanta Pharmaceuticals Inc
NASDAQ:ENTA |
$268.04 Million | $268.04 Million | USA | $13.27 | +2.79% | -4.46% | 4.44 Million |
| 455 |
Cytodyn Inc
OTCQB:CYDY |
$266.75 Million | $266.75 Million | USA | $0.21 | -8.70% | -8.70% | 12.36 Million |
| 456 |
Beijing Bohui Innovation Technology Co Ltd
SHE:300318 |
$266.67 Million | CN¥1.96 Billion | China | CN¥6.21 | -1.11% | +0.81% | 250.04 Million |
| 457 |
CHECKPOINT THER. DL-0001
F:CZTA |
$266.10 Million | €259.24 Million | Germany | €3.76 | +0.27% | +4.31% | 47.68K |
| 458 |
PYC Therapeutics Ltd
AU:PYC |
$264.67 Million | AU$427.45 Million | Australia | AU$1.37 | -2.50% | -7.77% | 37.12 Million |
| 459 |
MARAVAI LIFESC.HLD.A -01
F:MAR |
$264.39 Million | €257.57 Million | Germany | €2.66 | -0.75% | -13.07% | 12.81K |
| 460 |
CARsgen Therapeutics Holdings Limited
PINK:CRTHF |
$262.40 Million | $262.40 Million | USA | $0.76 | +0.00% | +0.00% | 0.00 |
| 461 |
Novogene Co. Ltd.
SHG:688315 |
$259.49 Million | CN¥1.90 Billion | China | CN¥14.31 | -0.49% | +0.85% | 85.48 Million |
| 462 |
Polaris Group
TW:6550 |
$258.65 Million | NT$8.56 Billion | Taiwan | NT$23.85 | +9.91% | -17.62% | 47.20 Million |
| 463 |
Fulcrum Therapeutics Inc
NASDAQ:FULC |
$258.51 Million | $258.51 Million | USA | $7.43 | -0.13% | -6.42% | 27.06 Million |
| 464 |
Design Therapeutics Inc
NASDAQ:DSGN |
$257.69 Million | $257.69 Million | USA | $11.04 | +0.45% | +6.46% | 5.94 Million |
| 465 |
Neumora Therapeutics, Inc.
NASDAQ:NMRA |
$257.45 Million | $257.45 Million | USA | $2.83 | -1.39% | -12.11% | 29.51 Million |
| 466 |
XOMA Corp
NASDAQ:XOMA |
$255.80 Million | $255.80 Million | USA | $27.00 | +1.47% | -1.64% | 3.33 Million |
| 467 |
R&G PharmaStudies Co. Ltd. A
SHE:301333 |
$255.16 Million | CN¥1.87 Billion | China | CN¥61.20 | -5.25% | -5.83% | 40.32 Million |
| 468 |
Hefei Lifeon Pharmaceutical Co Ltd
SHE:003020 |
$253.32 Million | CN¥1.86 Billion | China | CN¥24.33 | +0.00% | -0.04% | 33.02 Million |
| 469 |
TCM Biotech International Corp.
TWO:4169 |
$253.04 Million | NT$8.37 Billion | Taiwan | NT$220.00 | +0.23% | -8.52% | 6.56 Million |
| 470 |
Clinuvel Pharmaceuticals Ltd
AU:CUV |
$251.65 Million | AU$406.41 Million | Australia | AU$9.75 | -0.81% | -2.50% | 2.97 Million |
| 471 |
Niagen Bioscience, Inc.
NASDAQ:NAGE |
$251.41 Million | $251.41 Million | USA | $4.77 | -0.63% | -6.65% | 35.58 Million |
| 472 |
Wuhan Keqian Biology Co Ltd
SHG:688526 |
$250.98 Million | CN¥1.84 Billion | China | CN¥15.97 | -0.25% | +2.44% | 57.79 Million |
| 473 |
LENZ Therapeutics Inc
NASDAQ:LENZ |
$250.65 Million | $250.65 Million | USA | $12.50 | +6.47% | +1.63% | 17.65 Million |
| 474 |
OCUMENSION THER.DL-00001
F:5DG |
$249.54 Million | €243.11 Million | Germany | €0.82 | +10.07% | +16.31% | 528.00 |
| 475 |
Aura Biosciences Inc
NASDAQ:AURA |
$249.36 Million | $249.36 Million | USA | $6.81 | +1.04% | +20.11% | 5.89 Million |
| 476 |
I-MAB SPONS.ADS/1 -0001
F:0VY |
$249.02 Million | €242.59 Million | Germany | €2.48 | +1.64% | -16.22% | 228.10K |
| 477 |
Candel Therapeutics Inc
NASDAQ:CADL |
$245.32 Million | $245.32 Million | USA | $5.17 | +3.61% | +0.78% | 38.10 Million |
| 478 |
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518 |
$244.62 Million | CN¥1.79 Billion | China | CN¥2.96 | -1.66% | +5.71% | 339.15 Million |
| 479 |
Genfit S.A.
NASDAQ:GNFT |
$244.43 Million | $244.43 Million | USA | $5.97 | +0.00% | -3.71% | 49.82K |
| 480 |
Immutep Limited
PINK:PRRUF |
$244.42 Million | $244.42 Million | USA | $0.20 | +0.00% | +0.00% | 0.00 |
| 481 |
338840
KQ:338840 |
$243.70 Million | ₩356.82 Billion | Korea | ₩33900.00 | +0.00% | +47.71% | 6.11 Million |
| 482 |
389650
KQ:389650 |
$243.63 Million | ₩356.73 Billion | Korea | ₩70600.00 | +0.00% | +0.86% | 1.96 Million |
| 483 |
Lyell Immunopharma Inc
NASDAQ:LYEL |
$243.38 Million | $243.38 Million | USA | $20.14 | -4.69% | -21.02% | 2.66 Million |
| 484 |
AP Biosciences Inc
TWO:6945 |
$241.37 Million | NT$7.99 Billion | Taiwan | NT$173.50 | +3.89% | +2.36% | 9.35 Million |
| 485 |
Puma Biotechnology Inc
NASDAQ:PBYI |
$239.50 Million | $239.50 Million | USA | $6.14 | +1.15% | -1.29% | 11.10 Million |
| 486 |
Immuneering Corp
NASDAQ:IMRX |
$236.74 Million | $236.74 Million | USA | $4.80 | -3.23% | -14.59% | 18.26 Million |
| 487 |
Shanghai Hile Bio-tech
SHG:603718 |
$234.31 Million | CN¥1.72 Billion | China | CN¥4.86 | +0.00% | +3.62% | 551.81 Million |
| 488 |
Cabio Biotech Wuhan Co Ltd
SHG:688089 |
$233.18 Million | CN¥1.71 Billion | China | CN¥19.89 | +0.45% | +7.75% | 60.34 Million |
| 489 |
Hangzhou Biotest Biotech Co Ltd
SHG:688767 |
$231.15 Million | CN¥1.70 Billion | China | CN¥36.36 | -0.82% | -1.09% | 61.96 Million |
| 490 |
ToolGen Inc.
KQ:199800 |
$229.27 Million | ₩335.70 Billion | Korea | ₩48600.00 | +0.00% | +6.70% | 538.39K |
| 491 |
Green Cross
KO:005250 |
$228.88 Million | ₩335.13 Billion | Korea | ₩14040.00 | +0.86% | +4.23% | 2.56 Million |
| 492 |
Shenzhen Weiguang Biological Products Co Ltd
SHE:002880 |
$228.11 Million | CN¥1.67 Billion | China | CN¥29.65 | -2.24% | +1.06% | 147.95 Million |
| 493 |
Coherus BioSciences Inc
NASDAQ:CHRS |
$226.16 Million | $226.16 Million | USA | $1.68 | +1.20% | -12.95% | 42.41 Million |
| 494 |
Larimar Therapeutics Inc
NASDAQ:LRMR |
$224.89 Million | $224.89 Million | USA | $4.38 | -0.45% | -23.02% | 204.98 Million |
| 495 |
MEIRAGTX HLDGSDL-0000388
F:328 |
$224.40 Million | €218.61 Million | Germany | €6.40 | -2.29% | +8.47% | 170.00 |
| 496 |
Kyverna Therapeutics, Inc. Common Stock
NASDAQ:KYTX |
$223.25 Million | $223.25 Million | USA | $8.80 | -3.19% | +4.76% | 13.60 Million |
| 497 |
Clarity Pharmaceuticals Ltd
PINK:CLRPF |
$222.09 Million | $222.09 Million | USA | $0.97 | -19.17% | -35.33% | 84.20K |
| 498 |
PYCXF
PINK:PYCXF |
$221.01 Million | $221.01 Million | USA | $0.81 | +0.00% | +4.60% | 33.40K |
| 499 |
Vigil Neuroscience Inc
NASDAQ:VIGL |
$220.17 Million | $220.17 Million | USA | $8.05 | +0.00% | -0.12% | 23.19 Million |
| 500 |
Oxford Biomedica plc
PINK:OXBDF |
$220.17 Million | $220.17 Million | USA | $3.71 | +0.00% | -4.87% | 16.32K |
| 501 |
Cabaletta Bio Inc
NASDAQ:CABA |
$220.04 Million | $220.04 Million | USA | $3.10 | -3.13% | -5.20% | 62.27 Million |
| 502 |
Entrada Therapeutics Inc
NASDAQ:TRDA |
$220.00 Million | $220.00 Million | USA | $12.59 | -1.18% | -0.87% | 4.95 Million |
| 503 |
Invivyd Inc.
NASDAQ:IVVD |
$219.50 Million | $219.50 Million | USA | $1.59 | -4.79% | -15.87% | 48.25 Million |
| 504 |
Hansa Biopharma AB (publ)
PINK:HNSBF |
$217.34 Million | $217.34 Million | USA | $3.00 | +0.00% | +0.00% | 0.00 |
| 505 |
Zura Bio Limited Class A Ordinary Shares
NASDAQ:ZURA |
$215.48 Million | $215.48 Million | USA | $6.44 | +2.55% | -8.52% | 11.73 Million |
| 506 |
Shenzhen Bioeasy Biotechnology Co. Ltd.
SHE:300942 |
$213.89 Million | CN¥1.57 Billion | China | CN¥9.30 | -2.92% | -1.17% | 118.46 Million |
| 507 |
CK Life Sciences Int'l. (Holdings) Inc
F:LSI |
$213.50 Million | €208.00 Million | Germany | €0.09 | -0.57% | +3.59% | 33.94K |
| 508 |
2Seventy Bio Inc
NASDAQ:TSVT |
$213.50 Million | $213.50 Million | USA | $5.00 | +0.00% | +0.00% | 13.22 Million |
| 509 |
Assembly Biosciences Inc
NASDAQ:ASMB |
$212.78 Million | $212.78 Million | USA | $28.53 | -0.73% | -2.06% | 2.42 Million |
| 510 |
Jilin Jian Yisheng Pharmaceutical Co Ltd
SHE:002566 |
$212.09 Million | CN¥1.56 Billion | China | CN¥8.26 | -2.02% | -1.55% | 115.75 Million |
| 511 |
Inventiva S.A
PINK:IVEVF |
$211.70 Million | $211.70 Million | USA | $2.28 | +0.00% | +0.00% | 0.00 |
| 512 |
Ascletis Pharma Inc
PINK:ASCLF |
$209.01 Million | $209.01 Million | USA | $1.20 | +0.00% | +0.00% | 2.95K |
| 513 |
Hualan Biological Bacterin Inc.
SHE:301207 |
$208.60 Million | CN¥1.53 Billion | China | CN¥19.35 | -1.07% | -0.36% | 218.05 Million |
| 514 |
S.Biomedics Co. Ltd.
KQ:304360 |
$208.32 Million | ₩305.02 Billion | Korea | ₩34900.00 | +0.43% | +2.80% | 2.24 Million |
| 515 |
Guiyang Xintian Pharmaceutical Co Ltd
SHE:002873 |
$207.58 Million | CN¥1.52 Billion | China | CN¥10.22 | -2.01% | -0.97% | 135.16 Million |
| 516 |
Atrium Therapeutics, Inc. Common Stock
NASDAQ:RNA |
$207.28 Million | $207.28 Million | USA | $13.77 | -0.15% | -6.90% | 67.81 Million |
| 517 |
XOMA CORP.PRF.SH.SER.A 25
F:X0M |
$206.73 Million | €201.40 Million | Germany | €21.00 | -0.94% | +0.00% | 10.50K |
| 518 |
PepGen Ltd
NASDAQ:PEPG |
$204.50 Million | $204.50 Million | USA | $5.09 | -4.86% | -8.62% | 17.36 Million |
| 519 |
Palisade Bio Inc
NASDAQ:PALI |
$203.35 Million | $203.35 Million | USA | $1.99 | +0.00% | +14.37% | 76.77 Million |
| 520 |
Abeona Therapeutics Inc
NASDAQ:ABEO |
$202.79 Million | $202.79 Million | USA | $4.76 | -3.84% | -7.75% | 29.09 Million |
| 521 |
Cybin Inc
NYSE MKT:CYBN |
$202.22 Million | $202.22 Million | USA | $5.25 | -7.00% | -32.41% | 24.97 Million |
| 522 |
Protalix Biotherapeutics Inc
NYSE MKT:PLX |
$200.67 Million | $200.67 Million | USA | $2.79 | -2.79% | -3.12% | 29.31 Million |
| 523 |
Achieve Life Sciences Inc
NASDAQ:ACHV |
$200.27 Million | $200.27 Million | USA | $4.25 | +1.19% | +0.71% | 8.38 Million |
| 524 |
Voyager Therapeutics Inc
NASDAQ:VYGR |
$198.72 Million | $198.72 Million | USA | $3.92 | -9.26% | -4.62% | 20.90 Million |
| 525 |
ProKidney Corp.
NASDAQ:PROK |
$198.67 Million | $198.67 Million | USA | $2.13 | -0.93% | -10.88% | 13.60 Million |
| 526 |
Climb Bio Inc
NASDAQ:CLYM |
$198.54 Million | $198.54 Million | USA | $7.12 | -0.14% | -1.79% | 14.53 Million |
| 527 |
Greenwich Lifesciences Inc
NASDAQ:GLSI |
$197.29 Million | $197.29 Million | USA | $30.05 | +6.83% | +16.65% | 4.38 Million |
| 528 |
Qingdao Vland Biotech Co Ltd
SHG:603739 |
$196.98 Million | CN¥1.45 Billion | China | CN¥16.04 | +0.19% | +7.80% | 129.58 Million |
| 529 |
DiaMedica Therapeutics Inc
NASDAQ:DMAC |
$195.73 Million | $195.73 Million | USA | $7.16 | -0.28% | -8.09% | 4.45 Million |
| 530 |
Shattuck Labs Inc
NASDAQ:STTK |
$193.29 Million | $193.29 Million | USA | $5.95 | -1.16% | -1.16% | 13.86 Million |
| 531 |
Alector Inc
NASDAQ:ALEC |
$192.67 Million | $192.67 Million | USA | $2.23 | +0.90% | +1.83% | 20.45 Million |
| 532 |
enGene Holdings Inc. Common Stock
NASDAQ:ENGN |
$191.67 Million | $191.67 Million | USA | $7.25 | +0.28% | +2.84% | 11.64 Million |
| 533 |
Oryzon Genomics S.A
PINK:ORYZF |
$187.46 Million | $187.46 Million | USA | $3.10 | +0.00% | +0.00% | 0.00 |
| 534 |
Scpharmaceuticals Inc
NASDAQ:SCPH |
$185.50 Million | $185.50 Million | USA | $5.67 | +0.00% | +0.35% | 42.79 Million |
| 535 |
Protara Therapeutics Inc
NASDAQ:TARA |
$184.32 Million | $184.32 Million | USA | $5.45 | +0.55% | -5.22% | 28.06 Million |
| 536 |
C4 Therapeutics Inc
NASDAQ:CCCC |
$184.28 Million | $184.28 Million | USA | $2.76 | +1.10% | -23.12% | 68.64 Million |
| 537 |
Curacle Co. Ltd.
KQ:365270 |
$184.26 Million | ₩269.80 Billion | Korea | ₩19000.00 | -3.60% | +15.50% | 12.50 Million |
| 538 |
SANIONA AB (PUBL)
F:30S |
$183.59 Million | €178.86 Million | Germany | €1.44 | -2.96% | +8.08% | 19.35K |
| 539 |
Vicore Pharma Holding AB (publ)
ST:VICO |
$182.21 Million | Skr2.04 Billion | Sweden | Skr10.10 | +1.00% | +2.64% | 10.44 Million |
| 540 |
Humacyte Inc
NASDAQ:HUMA |
$182.16 Million | $182.16 Million | USA | $1.16 | +3.57% | -3.33% | 108.57 Million |
| 541 |
Caribou Biosciences Inc
NASDAQ:CRBU |
$181.77 Million | $181.77 Million | USA | $1.97 | +5.35% | +0.00% | 33.34 Million |
| 542 |
Shanghai Model Organisms Center Inc
SHG:688265 |
$181.19 Million | CN¥1.33 Billion | China | CN¥43.58 | -1.65% | +0.07% | 16.30 Million |
| 543 |
Santhera Pharmaceuticals Holding AG
PINK:SPHDF |
$181.15 Million | $181.15 Million | USA | $17.01 | +0.00% | +3.40% | 203.00 |
| 544 |
Shandong Sito Bio-technology Co Ltd
SHE:300583 |
$178.00 Million | CN¥1.31 Billion | China | CN¥14.78 | -1.79% | +1.23% | 63.06 Million |
| 545 |
Editas Medicine Inc
NASDAQ:EDIT |
$177.67 Million | $177.67 Million | USA | $2.46 | -3.15% | +6.03% | 42.83 Million |
| 546 |
ABEONA THERAPEUT. DL-01
F:PCJ |
$177.59 Million | €173.01 Million | Germany | €4.22 | +1.93% | +2.93% | 6.86K |
| 547 |
OmniAb Inc.
NASDAQ:OABI |
$177.13 Million | $177.13 Million | USA | $1.83 | +0.00% | -6.15% | 6.72 Million |
| 548 |
Avacta Group Plc
PINK:AVCTF |
$176.98 Million | $176.98 Million | USA | $0.52 | +0.00% | +0.87% | 8.00K |
| 549 |
MedinCell S.A
PINK:MDCLF |
$176.11 Million | $176.11 Million | USA | $6.98 | +0.00% | +0.00% | 0.00 |
| 550 |
Tonix Pharmaceuticals Holding Corp
NASDAQ:TNXP |
$176.11 Million | $176.11 Million | USA | $14.96 | +10.32% | +7.32% | 8.82 Million |
| 551 |
Innate Pharma
PINK:IPHYF |
$174.96 Million | $174.96 Million | USA | $2.90 | +0.00% | +0.00% | 0.00 |
| 552 |
NIBEC Co. Ltd
KQ:138610 |
$173.90 Million | ₩254.62 Billion | Korea | ₩28950.00 | -4.46% | +1.94% | 1.56 Million |
| 553 |
Forte Biosciences Inc
NASDAQ:FBRX |
$172.07 Million | $172.07 Million | USA | $26.44 | -3.71% | -5.50% | 4.30 Million |
| 554 |
Idorsia Ltd
PINK:IDRSF |
$171.80 Million | $171.80 Million | USA | $1.05 | +0.00% | -8.70% | 3.07K |
| 555 |
Supriya Lifescience Limited
NSE:SUPRIYA |
$169.31 Million | ₹14.66 Billion | India | ₹574.50 | -1.93% | -7.97% | 3.79 Million |
| 556 |
Adimmune Corp
TW:4142 |
$168.40 Million | NT$5.57 Billion | Taiwan | NT$17.50 | +0.86% | -1.69% | 45.20 Million |
| 557 |
Savior Lifetec
TWO:4167 |
$167.97 Million | NT$5.56 Billion | Taiwan | NT$20.50 | +0.49% | +11.11% | 49.30 Million |
| 558 |
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT |
$167.95 Million | $167.95 Million | USA | $6.39 | -3.62% | -13.18% | 10.95 Million |
| 559 |
Saniona AB
ST:SANION |
$167.38 Million | Skr1.88 Billion | Sweden | Skr15.16 | -4.53% | +5.42% | 28.67 Million |
| 560 |
Assure Tech Hangzhou Co Ltd
SHG:688075 |
$166.31 Million | CN¥1.22 Billion | China | CN¥39.48 | -0.38% | +3.46% | 12.89 Million |
| 561 |
Zhejiang East Asia Pharmaceutical Co. Ltd.
SHG:605177 |
$166.08 Million | CN¥1.22 Billion | China | CN¥22.60 | +0.67% | +4.24% | 49.36 Million |
| 562 |
Hubei Goto Biopharm Co.Ltd.
SHE:300966 |
$166.06 Million | CN¥1.22 Billion | China | CN¥20.86 | -2.66% | +1.51% | 41.93 Million |
| 563 |
Rezolute Inc
NASDAQ:RZLT |
$165.55 Million | $165.55 Million | USA | $2.56 | +2.81% | -21.47% | 62.46 Million |
| 564 |
PROTARA THERAPEUT.DL-001
F:1KPA |
$164.66 Million | €160.42 Million | Germany | €4.48 | +0.90% | -6.67% | 3.90K |
| 565 |
ANTENGENE CORP. DL-0001
F:722 |
$164.44 Million | €160.20 Million | Germany | €0.45 | -0.45% | -4.29% | 15.07K |
| 566 |
Y mAbs Therapeutics
NASDAQ:YMAB |
$162.66 Million | $162.66 Million | USA | $8.61 | +0.23% | +0.35% | 21.23 Million |
| 567 |
Zota Health Care LImited
NSE:ZOTA |
$162.20 Million | ₹14.05 Billion | India | ₹1104.30 | -5.66% | -9.66% | 1.03 Million |
| 568 |
PharmaEngine
TWO:4162 |
$161.48 Million | NT$5.34 Billion | Taiwan | NT$57.20 | -1.04% | -7.59% | 11.59 Million |
| 569 |
Avalo Therapeutics Inc
NASDAQ:AVTX |
$161.05 Million | $161.05 Million | USA | $15.38 | -4.00% | -11.15% | 13.90 Million |
| 570 |
Compugen
NASDAQ:CGEN |
$160.97 Million | $160.97 Million | USA | $2.27 | +0.00% | +5.58% | 7.57 Million |
| 571 |
Cellectis SA
NASDAQ:CLLS |
$160.13 Million | $160.13 Million | USA | $3.45 | -1.43% | -4.17% | 1.11 Million |
| 572 |
Hunan Nucien Pharmaceutical Co Ltd
SHG:688189 |
$159.21 Million | CN¥1.17 Billion | China | CN¥7.94 | -0.63% | +0.38% | 109.14 Million |
| 573 |
Gyre Therapeutics Inc.
NASDAQ:GYRE |
$157.00 Million | $157.00 Million | USA | $7.65 | +1.19% | -0.78% | 2.66 Million |
| 574 |
Eledon Pharmaceuticals Inc
NASDAQ:ELDN |
$156.79 Million | $156.79 Million | USA | $2.88 | +5.11% | -0.69% | 26.65 Million |
| 575 |
Opus Genetics, Inc.
NASDAQ:IRD |
$156.71 Million | $156.71 Million | USA | $4.80 | -7.51% | +0.63% | 26.05 Million |
| 576 |
ACELYRIN, INC. Common Stock
NASDAQ:SLRN |
$155.38 Million | $155.38 Million | USA | $2.27 | +0.00% | +11.00% | 23.90 Million |
| 577 |
308430
KQ:308430 |
$153.64 Million | ₩224.97 Billion | Korea | ₩27600.00 | -1.08% | +2.99% | 5.26 Million |
| 578 |
Starpharma Holdings Ltd
OTCQX:SPHRY |
$151.17 Million | $151.17 Million | USA | $0.59 | +0.00% | -6.35% | 1.30K |
| 579 |
Sagimet Biosciences Inc. Series A Common Stock
NASDAQ:SGMT |
$150.46 Million | $150.46 Million | USA | $5.19 | +0.97% | -3.53% | 9.05 Million |
| 580 |
Orchestra BioMed Holdings Inc.
NASDAQ:OBIO |
$150.17 Million | $150.17 Million | USA | $4.61 | +1.32% | -1.28% | 5.05 Million |
| 581 |
Digital Aria Co Ltd
KQ:115450 |
$150.03 Million | ₩219.68 Billion | Korea | ₩3000.00 | +1.69% | +4.90% | 9.82 Million |
| 582 |
BerGenBio ASA
PINK:BRRGF |
$147.25 Million | $147.25 Million | USA | $2.50 | +0.00% | +0.00% | 0.00 |
| 583 |
C6K0
F:C6K0 |
$146.82 Million | €143.04 Million | Germany | €13.66 | -0.44% | -6.05% | 839.00 |
| 584 |
Race Oncology Limited
PINK:RAONF |
$146.53 Million | $146.53 Million | USA | $1.22 | +0.00% | +0.00% | 0.00 |
| 585 |
SHANDONG BOAN BIOTECH.H 1
F:UJ9 |
$145.58 Million | €141.83 Million | Germany | €0.78 | +1.97% | +4.73% | 55.23K |
| 586 |
Taigen Biopharmaceuticals Holdings Ltd
TWO:4157 |
$145.40 Million | NT$4.81 Billion | Taiwan | NT$11.15 | -0.89% | -7.08% | 58.25 Million |
| 587 |
Suzhou Novoprotein Scientific Co. Ltd. A
SHG:688137 |
$145.38 Million | CN¥1.07 Billion | China | CN¥41.47 | -1.38% | +2.09% | 15.91 Million |
| 588 |
BioInvent International AB (publ)
PINK:BOVNF |
$144.95 Million | $144.95 Million | USA | $4.70 | +0.00% | +0.00% | 0.00 |
| 589 |
Genfit SA
PINK:GNFTF |
$144.56 Million | $144.56 Million | USA | $3.54 | +0.00% | +0.00% | 0.00 |
| 590 |
Foghorn Therapeutics Inc
NASDAQ:FHTX |
$144.38 Million | $144.38 Million | USA | $5.06 | +1.81% | -7.66% | 3.66 Million |
| 591 |
Galectin Therapeutics Inc
NASDAQ:GALT |
$144.10 Million | $144.10 Million | USA | $3.15 | -0.94% | -5.97% | 7.78 Million |
| 592 |
Shanghai Serum Bio-Technology Co. Ltd. A
SHG:688163 |
$144.05 Million | CN¥1.06 Billion | China | CN¥24.03 | -1.07% | +2.65% | 35.80 Million |
| 593 |
PROTALIX BIOTHERAP.DL-01
F:PBDA |
$143.64 Million | €139.93 Million | Germany | €2.38 | -2.46% | -1.65% | 19.43K |
| 594 |
Diamyd Medical AB (publ)
ST:DMYD-B |
$143.63 Million | Skr1.61 Billion | Sweden | Skr13.60 | -1.73% | -5.03% | 9.75 Million |
| 595 |
Elicio Therapeutics Inc.
NASDAQ:ELTX |
$143.62 Million | $143.62 Million | USA | $12.18 | +0.16% | +3.40% | 3.49 Million |
| 596 |
CAMP4 THERAPEUTICS CORPORATION
NASDAQ:CAMP |
$143.59 Million | $143.59 Million | USA | $5.55 | +1.28% | -11.55% | 8.18 Million |
| 597 |
Wecome Pharmaceutical Co Ltd
SHE:300878 |
$143.32 Million | CN¥1.05 Billion | China | CN¥28.53 | -2.93% | +1.46% | 76.12 Million |
| 598 |
Suzhou Fushilai Pharmaceutical Co. Ltd.
SHE:301258 |
$142.63 Million | CN¥1.05 Billion | China | CN¥33.43 | -3.49% | +0.24% | 23.73 Million |
| 599 |
Autolus Therapeutics plc
F:6A3A |
$140.22 Million | €136.60 Million | Germany | €1.28 | +1.59% | -8.57% | 48.91K |
| 600 |
Fennec Pharmaceuticals Inc
NASDAQ:FENC |
$139.80 Million | $139.80 Million | USA | $7.76 | -0.51% | +2.24% | 3.00 Million |
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries